DBV Technologies (DBVT) Asset Writedowns and Impairment (2024 - 2026)

DBV Technologies (DBVT) posted quarterly Asset Writedowns and Impairment of $2.6 million for Q2 2026, down 56.67% year-on-year from $6.0 million in Q2 2025, and down 13.33% on a QoQ basis from $3.0 million in Q1 2026.

DBV Technologies (DBVT) Asset Writedowns and Impairment (2024 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Asset Writedowns and Impairment for 3 consecutive years, with $2.6 million the latest figure, recorded in Q2 2026.

  • Quarterly Asset Writedowns and Impairment fell 56.67% year-over-year to $2.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.4 million (up 9.26% YoY) and the FY2025 annual result came in at $16.1 million, up 1057.2% from the prior year.
  • Asset Writedowns and Impairment fell to $2.6 million in Q2 2026 per DBVT's latest filing, from $3.0 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for DBVT reached as high as $6.0 million in Q2 2025 and fell as low as $99000.0 in Q3 2024.
  • A 3-year average of $2.9 million and a median of $2.8 million in 2026 frame the typical range for Asset Writedowns and Impairment.
  • Annual changes were most pronounced in 2025 — Asset Writedowns and Impairment surged 3567.68% — and 2026, when it slumped 56.67%.
  • Year by year, Asset Writedowns and Impairment stood at $99000.0 in 2024, then jumped by 2052.53% to $2.1 million in 2025, then increased by 22.01% to $2.6 million in 2026.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $2.6 million, $3.0 million, and $2.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 DBV Technologies 267.50 Mn 92.60 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 2.60 Mn
Jun 30, 2026 2.60 Mn
Mar 31, 2026 3.00 Mn
Mar 31, 2026 3.00 Mn
Dec 31, 2025 2.13 Mn
Dec 31, 2025 2.13 Mn
Sep 30, 2025 3.63 Mn
Sep 30, 2025 3.63 Mn
Jun 30, 2025 6.00 Mn
Jun 30, 2025 6.00 Mn
Mar 31, 2025 4.30 Mn
Mar 31, 2025 4.30 Mn
Sep 30, 2024 99,000.00
Sep 30, 2024 99,000.00
Mar 31, 2024 1.29 Mn
Mar 31, 2024 1.29 Mn